VolitionRX Ltd VNRX:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
0.6234quote price arrow up+0.0062 (+1.0045%)
Volume
243,610
52 week range
0.55 - 2.10
Loading...
  • Open0.63
  • Day High0.65
  • Day Low0.57
  • Prev Close0.6172
  • 52 Week High2.10
  • 52 Week High Date05/03/23
  • 52 Week Low0.55
  • 52 Week Low Date12/13/23

Key Stats

  • Market Cap51.161M
  • Shares Out82.07M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.38
  • YTD % Change-14.09

KEY STATS

  • Open0.63
  • Day High0.65
  • Day Low0.57
  • Prev Close0.6172
  • 52 Week High2.10
  • 52 Week High Date05/03/23
  • 52 Week Low0.55
  • 52 Week Low Date12/13/23
  • Market Cap51.161M
  • Shares Out82.07M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.38
  • YTD % Change-14.09

RATIOS/PROFITABILITY

  • EPS (TTM)-0.50
  • P/E (TTM)-1.24
  • Fwd P/E (NTM)-1.44
  • EBITDA (TTM)-34.576M
  • ROE (TTM)-5,396.83%
  • Revenue (TTM)775,300.026
  • Gross Margin (TTM)-
  • Net Margin (TTM)-4,601.71%
  • Debt To Equity (MRQ)-73.81%

EVENTS

  • Earnings Date05/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On VolitionRX Ltd

 

Profile

MORE
VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such...
Martin Faulkes
Executive Chairman of the Board
Cameron Reynolds
President, Chief Executive Officer, Director
Gaetan Michel
Chief Operating Officer
Terig Hughes
Chief Financial Officer, Treasurer
Nicholas Plummer
Group General Counsel
Address
1489 West Warm Springs Road, Suite 110
Henderson, NV
89014
United States

Top Peers

SYMBOLLASTCHG%CHG
QTTB
Q32 Bio Inc
22.49-1.89-7.75%
AVRO
AVROBIO Inc
1.20-0.04-3.23%
RPHM
Reneo Pharmaceuticals Inc
1.74-0.02-1.14%
NXTC
NextCure Inc
1.60+0.03+1.91%
MTNB
Matinas BioPharma Holdings Inc
0.1877-0.0023-1.2105%